INDENTUREMgi Pharma Inc • March 4th, 2004 • Pharmaceutical preparations • New York
Exhibit 10.1 DEVELOPMENT, MARKETING AND COOPERATION AGREEMENT ------------------------------------------------ THIS AGREEMENT is made as of October 23, 1995, by and between MGI PHARMA, INC. ("MGI"), 300E Opus Center, 9900 Bren Road East, Minneapolis,...Agreement • November 9th, 1995 • Mgi Pharma Inc • Pharmaceutical preparations • Minnesota
EXHIBIT 10.2 ------------ STOCK PURCHASE AGREEMENT THIS AGREEMENT is made on August 2, 2000 in the City of Montreal, Quebec. BETWEEN: METHYLGENE INC., a corporation incorporated under the laws of Canada (hereinafter referred to as the "Corporation")...Stock Purchase Agreement • August 11th, 2000 • Mgi Pharma Inc • Pharmaceutical preparations • Quebec
AND NORWEST BANK MINNESOTA, N. A., RIGHTS AGENTRights Agreement • July 15th, 1998 • Mgi Pharma Inc • Pharmaceutical preparations • Minnesota
Recitals --------License Agreement • May 5th, 2000 • Mgi Pharma Inc • Pharmaceutical preparations • Minnesota
ARTICLE 1 DEFINITIONSAsset Purchase Agreement • November 14th, 2000 • Mgi Pharma Inc • Pharmaceutical preparations • Maryland
This Agreement is made as of the 1st day of January, 1992, between MGI PHARMA, INC., a Minnesota corporation, with its principal offices at Suite 300E Opus Center, 9900 Bren Road East, Minnetonka, Minnesota 55343 (the "Company") and Lori-jean Gille...Termination Agreement • March 22nd, 1996 • Mgi Pharma Inc • Pharmaceutical preparations
Exhibit 99.2 ------------ Supply and Purchase AgreementAgreement • April 25th, 2001 • Mgi Pharma Inc • Pharmaceutical preparations
FORM OF CONVERTIBLE SUBORDINATED PROMISSORY NOTEMgi Pharma Inc • December 4th, 2002 • Pharmaceutical preparations • New York
AMENDMENT NO. 1 TO RIGHTS AGREEMENTRights Agreement • March 20th, 2000 • Mgi Pharma Inc • Pharmaceutical preparations
EXHIBIT 10.15 SEPARATION AGREEMENT AND MUTUAL RELEASE ------------------ This Separation Agreement and Mutual Release ("Separation Agreement") is made and entered into this 22nd day of October, 1996, by and between Rajesh C. Shrotriya, M.D....Separation Agreement • March 28th, 1997 • Mgi Pharma Inc • Pharmaceutical preparations • Minnesota
Exhibit 4.1 MGI PHARMA, INC. (a Minnesota corporation) Senior Subordinated Convertible Notes due 2024 PURCHASE AGREEMENT Dated: February 25, 2004 TABLE OF CONTENTSPurchase Agreement • March 4th, 2004 • Mgi Pharma Inc • Pharmaceutical preparations • New York
Exhibit 10.2 CONTROL AGREEMENT This CONTROL AGREEMENT (the "Agreement") dated as of March 2, 2004 by and among MGI Pharma, Inc. (the "Pledgor") and Wells Fargo Bank, National Association, in its capacity as trustee (the "Trustee"), and Wells Fargo...Control Agreement • March 4th, 2004 • Mgi Pharma Inc • Pharmaceutical preparations • New York
RecitalsLicense Agreement • February 14th, 2001 • Mgi Pharma Inc • Pharmaceutical preparations • Minnesota
EXHIBIT 10.31 ------------- LEASE AGREEMENT (Multi-Tenant Industrial) INDEX -----Lease Agreement • March 22nd, 2001 • Mgi Pharma Inc • Pharmaceutical preparations
EXHIBIT 10.25 EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • March 30th, 1999 • Mgi Pharma Inc • Pharmaceutical preparations • California
Exhibit 10.25 MANUFACTURING AGREEMENT This Manufacturing Agreement (the "Agreement") is made and entered into effective as of December 12, 1995, by and between MGI PHARMA, INC., a Minnesota corporation ("MGI"), and GLOBAL PHARM INC., a corporation...Manufacturing Agreement • March 22nd, 1996 • Mgi Pharma Inc • Pharmaceutical preparations • Minnesota
ARTICLE 1 DEFINITIONSPromotion Agreement • May 14th, 1999 • Mgi Pharma Inc • Pharmaceutical preparations
Exhibit 10.1 SEPARATION AGREEMENT Lori-jean Gille ("Employee") and MGI Pharma, Inc. ("Employer"), desiring to facilitate a mutually agreeable separation and smooth transition of duties, hereby agree as follows: 1. Employee hereby resigns from all...Separation Agreement • August 13th, 1999 • Mgi Pharma Inc • Pharmaceutical preparations
FORM OF COMMON STOCK PURCHASE WARRANTMgi Pharma Inc • December 4th, 2002 • Pharmaceutical preparations • New York
BACKGROUNDSupply and License Agreement • March 31st, 1998 • Mgi Pharma Inc • Pharmaceutical preparations
EXHIBIT 10.4 CO-EXCLUSIVE MARKETING AGREEMENT THIS AGREEMENT is made as of the 29th day of June, 1999 (the "Effective Date"), by and between PHARMACIA & UPJOHN COMPANY, a corporation organized and existing under the laws of the state of Delaware, with...Exclusive Marketing Agreement • August 13th, 1999 • Mgi Pharma Inc • Pharmaceutical preparations
Exhibit 10.29 ------------- TERMINATION AGREEMENT This Agreement is made as of the 16th day of January, 2001, between MGI PHARMA, INC., a Minnesota corporation, with its principal offices at 6300 West Old Shakopee Road, Suite #110, Bloomington,...Termination Agreement • March 29th, 2002 • Mgi Pharma Inc • Pharmaceutical preparations
TERMINATION AGREEMENTTermination Agreement • April 27th, 2006 • Mgi Pharma Inc • Pharmaceutical preparations
This Agreement is made as of the April 21, 2006, between MGI PHARMA, INC., a Minnesota corporation, with its principal offices at 5775 West Old Shakopee Road, Suite #100, Bloomington, Minnesota 55437 (the “Company”) and William F. Spengler (“Employee”), residing at 3812 Fenchurch Road, Baltimore, MD 21218.
Exhibit 4.3 REGISTRATION RIGHTS AGREEMENT Dated March 2, 2004Registration Rights Agreement • March 4th, 2004 • Mgi Pharma Inc • Pharmaceutical preparations • New York
EXHIBIT 1.1 ----------- 1,000,000 Shares MGI PHARMA, INC. Common Stock, par value $0.01 per share FORM OF PLACEMENT AGENCY AGREEMENT ----------------------------------Mgi Pharma Inc • May 18th, 2000 • Pharmaceutical preparations • Minnesota
EXHIBIT 10.2 LEASELease • August 13th, 1999 • Mgi Pharma Inc • Pharmaceutical preparations • Minnesota
Exhibit 10.15 TERMINATION AGREEMENTTermination Agreement • March 22nd, 1996 • Mgi Pharma Inc • Pharmaceutical preparations
EXHIBIT 10.1 ------------ STAND-BY PURCHASE AGREEMENTStand-by Purchase Agreement • March 1st, 2001 • Mgi Pharma Inc • Pharmaceutical preparations • New York
EXHIBIT 1.1 ----------- COMMON STOCK UNDERWRITING AGREEMENTCommon Stock Underwriting Agreement • March 1st, 2001 • Mgi Pharma Inc • Pharmaceutical preparations • New York
CREDIT AGREEMENT dated as of October 18, 2006 among MGI PHARMA, INC., as a Borrower MGI GP, INC., as a Borrower MGI OM, INC., as a Borrower The Other Loan Parties The Lenders Party Hereto and JPMORGAN CHASE BANK, N.A., as Administrative Agent, Sole...Credit Agreement • October 24th, 2006 • Mgi Pharma Inc • Pharmaceutical preparations • New York
CREDIT AGREEMENT dated as of October 18, 2006 (as it may be amended or modified from time to time, this “Agreement”), among MGI PHARMA, INC., a Minnesota corporation, MGI GP, INC., a Delaware corporation, and MGI OM, INC., a Delaware corporation, as Borrowers, the other Loan Parties party thereto, the Lenders party hereto, and JPMORGAN CHASE BANK, N.A., as Administrative Agent.
Exhibit 10.9 RETIREMENT, SEPARATION AGREEMENT AND RELEASE This Retirement, Separation Agreement and Release ("Agreement") effective this 31st day of December, 1995, by and between MGI PHARMA, INC., a Minnesota corporation ("MGI"), and Dr. Kenneth F....Retirement, Separation Agreement and Release • March 22nd, 1996 • Mgi Pharma Inc • Pharmaceutical preparations • Minnesota
Exhibit 10.1 PLEDGE AGREEMENT This PLEDGE AGREEMENT (the "Pledge Agreement") is made and entered into as of March 2, 2004 by MGI PHARMA, INC., a Minnesota corporation (the "Pledgor"), having its principal office at 5775 West Old Shakopee Road, Suite...Pledge Agreement • March 4th, 2004 • Mgi Pharma Inc • Pharmaceutical preparations • New York
December 14, 2007 Leon O. Moulder, Jr. Dear Leon:Merger Agreement • December 21st, 2007 • Mgi Pharma Inc • Pharmaceutical preparations
AGREEMENT AND PLAN OF MERGER by and among EISAI CO., LTD. JAGUAR ACQUISITION CORP. and MGI PHARMA, INC. Dated as of December 10, 2007Agreement and Plan of Merger • December 11th, 2007 • Mgi Pharma Inc • Pharmaceutical preparations • New York
This AGREEMENT AND PLAN OF MERGER (this “Agreement”) is dated as of December 10, 2007, by and among Eisai Co., Ltd., a corporation organized under the laws of Japan (“Parent”), Jaguar Acquisition Corp., a Minnesota corporation and an indirect wholly-owned subsidiary of Parent (“Purchaser”), and MGI PHARMA, INC., a Minnesota corporation (the “Company”).
